Literature DB >> 15730395

Clinical investigation: increased serum stromal derived factor 1 alpha levels in pulmonary tuberculosis.

K Mizuno1, W Matsuyama, H Mitsuyama, M Watanabe, I Higashimoto, M Osame, K Arimura.   

Abstract

Pulmonary tuberculosis, a granulomatous disease, has few serological markers for its activity. Recently, an increased plasma level of stromal derived factor 1 alpha (SDF-1alpha), which can induce strong chemotaxis of cells through its receptor CXCR4, was detected in patients with tuberculosis. In this study we investigated serum SDF-1alpha levels and CXCR4 expression on peripheral blood mononuclear cells (PBMCs). Fifty-five active tuberculosis patients, 30 resolved tuberculosis patients, 27 acute bronchitis patients and 8 healthy volunteers were examined. Histological expression of SDF-1alpha in the tuberculosis lesion and CXCR4 expression of PBMCs were also analysed. Serum SDF-1alpha levels in active tuberculosis patients were significantly higher than other groups. The sensitivity and specificity for the diagnosis of active tuberculosis was 88.5% and 85.3% (cutoff value = 650 pg/ml), respectively. CXCR4 expression levels on PBMCs showed a significant negative correlation with serum SDF-1alpha levels. Inflammatory cells including multinuclear giant cells in the lesion expressed SDF-1alpha. Measurement of serum SDF-1alpha could be a useful screening marker for the identification of active pulmonary tuberuculosis. We propose that interaction of SDF-1alpha and CXCR4 might be involved in the pathogenesis of pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730395      PMCID: PMC1809316          DOI: 10.1111/j.1365-2249.2005.02721.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

Review 1.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 2.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.

Authors:  T Katsuta; C Lim; K Shimoda; K Shibuta; P Mitra; B F Banner; M Mori; G F Barnard
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

4.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice.

Authors:  H Yamagami; T Matsumoto; N Fujiwara; T Arakawa; K Kaneda; I Yano; K Kobayashi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.

Authors:  Y Sotsios; G C Whittaker; J Westwick; S G Ward
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

6.  Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis.

Authors:  W Matsuyama; T Hashiguchi; K Matsumuro; F Iwami; Y Hirotsu; M Kawabata; K Arimura; M Osame
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

7.  Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis.

Authors:  S Shalekoff; S Pendle; D Johnson; D J Martin; C T Tiemessen
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

8.  Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.

Authors:  Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.

Authors:  Alex Soriano; Catalina Martínez; Felipe García; Montserrat Plana; Eduard Palou; Marylène Lejeune; Juan I Aróstegui; Elisa De Lazzari; Carmen Rodriguez; Alicia Barrasa; José I Lorenzo; José Alcamí; Jorge del Romero; José M Miró; José M Gatell; Teresa Gallart
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

Review 10.  New tools for the diagnosis of tuberculosis: the perspective of developing countries.

Authors:  J Foulds; R O'Brien
Journal:  Int J Tuberc Lung Dis       Date:  1998-10       Impact factor: 2.373

View more
  2 in total

1.  Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.

Authors:  Jeong Sup Song; Chun Mi Kang; Hyeon Hui Kang; Hyung Kyu Yoon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

2.  E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4.

Authors:  Jie Sun; Yuhua Li; Gina M Graziani; Lionel Filion; David S Allan
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.